27
Medical 21, Inc. files Form D
Company raise update · Raising · Offering $20M · Sold $10M · PLYMOUTH, MN · filed 2025-08-21
47
Medical 21 raises $20M in Regulation D offering from Plymouth, Minnesota biotech
Company raise · Raising · PLYMOUTH, MN · Form D filed 2026-10-23
Medical 21, Inc., a Minnesota-incorporated biotechnology company based in Plymouth, is raising $20M under Regulation D exemption 6(b). The company has sold $550K to three investors so far and is seeking $19.45M more.
$10M+ raiseother
Why now — by persona
- Executive & technical recruiting:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- B2B software & services sales:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Commercial banking / treasury:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- D&O and management-liability insurance:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
- Outsourced accounting / CFO:A concrete reason to call this issuer this week, citing the filing. Subscribe to unlock
People on the filing
| Manny Villafana | Executive Officer, Director |
| Eric Solien | Executive Officer |
| Jeff Vreeman | Executive Officer |
| Andrea Sweeney | Executive Officer |
Signed by Manny Villafana, Chief Executive Officer.
Filing contact
The issuer's phone number and address from the filing are shown to subscribers. See plans, or read it on EDGAR.